Interventional x-ray, mobile C-arm markets saw recovery in 2021

2019 02 15 18 26 2638 Interventional Radiology 400

The world market for interventional x-ray and mobile C-arm equipment is forecast to reach over $4.9 billion by 2026, according to a new report from Signify Research. The world markets for interventional x-ray systems and mobile C-arms increased by 10.2% and 15.5%, respectively, in 2021. The markets recovered strongly as the negative impact of the coronavirus pandemic subsided, and delayed orders were fulfilled.

Product trends

In the mobile C-arm market, flat-panel detector (FPD) 2D mobile C-arms are forecast to have the fastest growth through to 2026, with a growth in revenue at a compound annual growth rate (CAGR) of 6.5%.

Demand for image intensifier systems is being maintained by emerging regions or low-risk applications such as pain management in developed countries. The U.S., China, Japan, and Western Europe will continue to lead adoption of 3D C-arm technology.

However, the penetration of 3D mobile C-arms must overcome barriers in the U.S. market, such as strong preferences for hybrid operating rooms and Medtronic's O-arm for spinal surgery due to favorable reimbursement.

world mobile c arm market by product type

Within the interventional x-ray market, strong growth is projected for the structural heart market, with left atrial appendage closure procedures and mitral valve interventions maintaining clinical demand.

Interventional neurology is a key growth area within interventional radiology. The increasing number of stroke centers globally, as well as adoption of biplane systems for multidisciplinary use, for instance for vascular procedures, is driving demand for interventional neurology systems. The primary applications for hybrid operating rooms include cardiac and vascular procedures, followed by spinal procedures.

World interventional x ray market by product type

Regional trends


  • As clinical cases become more complex and interventional x-ray technology becomes more advanced, it is becoming increasingly difficult for interventionalists to gain expertise across all available software and applications.
  • An increase in the complexity of interventional procedures supports demand for high-end solutions, in which the required generator power is regulated to ensure patient safety. Most new demand for mobile C-arm technology will be accounted for by outpatient clinics and facilities in the U.S.
  • Most countries in Latin America have budget constraints and are price-sensitive, so they tend to purchase low-end to midrange systems rather than higher-end systems. In Brazil, there has been a transition from image intensifier technology toward midrange and low-end mobile 2D FPD C-arms with basic functionality to support simple surgery. The rest of Latin America has both emerging and developed markets, with pockets of strong growth coming from Colombia, Argentina, and Chile.

Europe, Middle East, Africa (EMEA)

  • Western European governments are expected to focus on healthcare reforms, cost-containment, and increasing return on investment throughout the forecast period. Demand for interventional x-ray systems is therefore dependent on the expansion of existing healthcare facilities, such as larger, new hospitals to replace older hospitals and new cardiac centers.
  • The Western European market has a strong preference for floor-mounted radiography systems. There is a greater uptake of 2D and 3D FPD systems compared with Eastern Europe, with the German market having the highest uptake of 3D C-arms in 2021.
  • Higher-specification, higher-cost equipment is typically purchased in Northern Africa and South Africa, while central Africa is predominantly a very low-end interventional x-ray market.
  • In Eastern Europe, Poland is forecast to be a growth market as European structural and investment funds will support healthcare investment over the coming years.


  • China is the second largest market for interventional x-ray systems, after the U.S. A key growth driver is the rapidly increasing number of tier 1 hospitals in China.
  • India has one of the best practices for cardiovascular medicine globally, ranking the third highest country for the number of transcatheter aortic valve implantation (TAVI) procedures performed. From a clinical standpoint, the increasing number of stent procedures is facilitating additional growth for cardiac catheterization labs and better utilization of existing cardiac catheterization labs.
  • Demand for image intensifier-based mobile C-arms is falling in China, with 2D FPD mobile C-arms accounting for most of the market. Strong price erosion due to increased competition amongst local mobile C-arm vendors in China is hindering revenue growth. Low-cost mobile C-arm systems in India tend to fall into the super-value market segment, which accounts for more than 70% of the total mobile C-arm market in India.

Future outlook

In the coming years, market growth for both interventional and surgical x-ray equipment is forecast to be positive following a year of market retraction in 2020. Beyond the pandemic, the main growth drivers will continue to be the growing burden of chronic diseases owing to changing lifestyles and the rising need for cost-effective, minimally invasive interventional procedures.

The rising prevalence of chronic conditions, such as cancer, heart disease, and others, and advances in minimally invasive, targeted treatments using imaging guidance continue to drive the market. Increasing competition from Asian manufacturers is increasing the affordability and adoption of image-guided therapy systems in emerging countries.

The increased demand for complex neurology, oncology, and cardiovascular procedures means that hospitals are increasingly prioritizing advanced multidisciplinary equipment. Advanced features such as artificial intelligence (AI), radiation dose management, and treatment-planning capabilities will increase the uptake of more high-end technology in developed countries.

Within the mobile C-arm market, positive growth from 2021 onwards is attributed to the rising geriatric population with a high susceptibility to chronic conditions such as cardiovascular, orthopedic, and respiratory diseases. This, alongside increasing patient awareness of the benefits of minimally invasive procedures, is expected to drive market growth over the forecast period.

Bhvita Jani is a senior marketing analyst at Signify Research. This information was derived from Signify Research's Interventional & Surgical X-ray Equipment - World - 2022, published July 2022. For more information visit Signify's website.

The comments and observations expressed are those of the author and do not necessarily reflect the opinions of

Page 1 of 374
Next Page